- Home
- KRRO vs ALEC Comparison
KRRO vs ALEC Comparison
Compare KRRO & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- ALEC
- Stock Information
- Founded
- KRRO 2014
- ALEC 2013
- Country
- KRRO United States
- ALEC United States
- Employees
- KRRO N/A
- ALEC N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KRRO Health Care
- ALEC Health Care
- Exchange
- KRRO Nasdaq
- ALEC Nasdaq
- Market Cap
- KRRO 147.4M
- ALEC 124.0M
- IPO Year
- KRRO 2019
- ALEC 2019
- Fundamental
- Price
- KRRO $33.22
- ALEC $3.13
- Analyst Decision
- KRRO Strong Buy
- ALEC Buy
- Analyst Count
- KRRO 7
- ALEC 7
- Target Price
- KRRO $96.71
- ALEC $4.50
- AVG Volume (30 Days)
- KRRO 237.0K
- ALEC 1.2M
- Earning Date
- KRRO 11-11-2025
- ALEC 11-05-2025
- Dividend Yield
- KRRO N/A
- ALEC N/A
- EPS Growth
- KRRO N/A
- ALEC N/A
- EPS
- KRRO N/A
- ALEC N/A
- Revenue
- KRRO $6,281,000.00
- ALEC $81,130,000.00
- Revenue This Year
- KRRO $97.27
- ALEC N/A
- Revenue Next Year
- KRRO N/A
- ALEC $290.50
- P/E Ratio
- KRRO N/A
- ALEC N/A
- Revenue Growth
- KRRO N/A
- ALEC 46.77
- 52 Week Low
- KRRO $10.29
- ALEC $0.87
- 52 Week High
- KRRO $98.00
- ALEC $6.37
- Technical
- Relative Strength Index (RSI)
- KRRO 67.72
- ALEC 66.38
- Support Level
- KRRO $30.36
- ALEC $2.71
- Resistance Level
- KRRO $37.03
- ALEC $3.18
- Average True Range (ATR)
- KRRO 3.68
- ALEC 0.23
- MACD
- KRRO -0.07
- ALEC 0.00
- Stochastic Oscillator
- KRRO 77.36
- ALEC 94.32
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.